4.6 Article

Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study

期刊

PLOS ONE
卷 11, 期 6, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0157218

关键词

-

资金

  1. National Institutes of Health [R01AG038791, R01AG032306]
  2. Frontotemporal Lobar Degeneration Clinical Research Consortium [U54NS092089]
  3. Tau Consortium
  4. Veterans Affairs Medical Center, San Francisco, California

向作者/读者索取更多资源

Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) are both 4 microtubule binding repeat tauopathy related disorders. Clinical trials need new biomarkers to assess the effectiveness of tau-directed therapies. This study investigated the regional distribution of longitudinal diffusion tensor imaging changes, measured by fractional anisotropy, radial and axial diffusivity over 6 months median interval, in 23 normal control subjects, 35 patients with PSP, and 25 patients with CBS. A mixed-effects framework was used to test longitudinal changes within and between groups. Correlations between changes in diffusion variables and clinical progression were also tested. The study found that over a 6 month period and compared to controls, the most prominent changes in PSP were up to 3 +/- 1% higher rates of FA reduction predominantly in superior cerebellar peduncles, and up to 18 +/- 6% higher rates of diffusivity increases in caudate nuclei. The most prominent changes in CBS compared to controls were up to 4 +/- 1% higher rates of anisotropy reduction and 18 +/- 6% higher rates of diffusivity increase in basal ganglia and widespread white matter regions. Compared to PSP, CBS was mainly associated with up to 3 +/- 1% greater rates of anisotropy reduction around the central sulci, and 11 +/- 3% greater rates of diffusivity increase in superior fronto-occipital fascicules. Rates of diffusivity increases in the superior cerebellar peduncle correlated with rates of ocular motor decline in PSP patients. This study demonstrated that longitudinal diffusion tensor imaging measurement is a promising surrogate marker of disease progression in PSP and CBS over a relatively short period.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Behavioral Sciences

Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort

Phoebe H. Foster, Lucy L. Russell, Georgia Peakman, Rhian S. Convery, Arabella Bouzigues, Caroline Greaves, Martina Bocchetta, David M. Cash, John C. van Swieten, Lize C. Jiskoot, Fermin Moreno, Raquel Sanchez-Valle, Robert Laforce, Caroline Graff, Mario Masellis, Carmela Tartaglia, James B. Rowe, Barbara Borroni, Elizabeth Finger, Matthis Synofzik, Daniela Galimberti, Rik Vandenberghe, Alexandre de Mendonca, Chris R. Butler, Alex Gerhard, Simon Ducharme, Isabelle Le Ber, Fabrizio Tagliavini, Isabel Santana, Florence Pasquier, Johannes Levin, Adrian Danek, Markus Otto, Sandro Sorbi, Jonathan D. Rohrer

Summary: Significant empathy deficits are present in genetic frontotemporal dementia (FTD). Individuals with symptomatic and behavioral variant FTD phenotype, as well as C9orf72 expansion carriers, score lower on empathy assessments.

CORTEX (2022)

Article Clinical Neurology

Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort

Kelly M. Sunderland, Derek Beaton, Stephen R. Arnott, Peter Kleinstiver, Donna Kwan, Jane M. Lawrence-Dewar, Joel Ramirez, Brian Tan, Robert Bartha, Sandra E. Black, Michael Borrie, Donald Brien, Leanne K. Casaubon, Brian C. Coe, Benjamin Cornish, Allison A. Dilliott, Dar Dowlatshahi, Elizabeth Finger, Corinne Fischer, Andrew Frank, Julia Fraser, Morris Freedman, Barry Greenberg, David A. Grimes, Ayman Hassan, Wendy Hatch, Robert A. Hegele, Christopher Hudson, Mandar Jog, Sanjeev Kumar, Anthony Lang, Brian Levine, Wendy Lou, Jennifer Mandzia, Connie Marras, William McIlroy, Manuel Montero-Odasso, David G. Munoz, Douglas P. Munoz, Joseph B. Orange, David S. Park, Stephen H. Pasternak, Frederico Pieruccini-Faria, Tarek K. Rajji, Angela C. Roberts, John F. Robinson, Ekaterina Rogaeva, Demetrios J. Sahlas, Gustavo Saposnik, Christopher J. M. Scott, Dallas Seitz, Christen Shoesmith, Thomas D. L. Steeves, Michael J. Strong, Stephen C. Strother, Richard H. Swartz, Sean Symons, David F. Tang-Wai, Maria Carmela Tartaglia, Angela K. Troyer, John Turnbull, Lorne Zinman, Paula M. McLaughlin, Mario Masellis, Malcolm A. Binns

Summary: This is a multi-site, longitudinal, observational cohort study that aims to understand the impact of neurodegenerative and cerebrovascular diseases on dementia presentation. The study recruited 520 participants with prevalent neurodegenerative and cerebrovascular diseases and comprehensively assessed them. Results showed that the participants were predominantly White males with higher education levels. The data will be shared with the global scientific community to identify markers of disease severity, progression, and therapy targets.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Proposed research criteria for prodromal behavioural variant frontotemporal dementia

Megan S. Barker, Reena T. Gottesman, Masood Manoochehri, Silvia Chapman, Brian S. Appleby, Danielle Brushaber, Katrina L. Devick, Bradford C. Dickerson, Kimiko Domoto-Reilly, Julie A. Fields, Leah K. Forsberg, Douglas R. Galasko, Nupur Ghoshal, Jill Goldman, Neill R. Graff-Radford, Murray Grossman, Hilary W. Heuer, Ging-Yuek Hsiung, David S. Knopman, John Kornak, Irene Litvan, Ian R. Mackenzie, Joseph C. Masdeu, Mario F. Mendez, Belen Pascual, Adam M. Staffaroni, Maria Carmela Tartaglia, Bradley F. Boeve, Adam L. Boxer, Howard J. Rosen, Katherine P. Rankin, Stephanie Cosentino, Katya Rascovsky, Edward D. Huey

Summary: Currently, there are no research criteria for diagnosing prodromal behavioural variant frontotemporal dementia (bvFTD), but early detection is highly important for research purposes. This study aimed to develop and validate a proposed set of research criteria for prodromal bvFTD called 'mild behavioural and/or cognitive impairment in bvFTD' (MBCI-FTD). The criteria included seven core features and supportive features, and showed high accuracy in classifying prodromal bvFTD.
Review Clinical Neurology

Recent Advances in Frontotemporal Dementia

Maria Carmela Tartaglia, Ian R. A. Mackenzie

Summary: Frontotemporal dementia is a devastating neurodegenerative condition for which there is currently no effective treatment. Recent molecular discoveries provide a foundation for the development of biomarkers and targeted therapies.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2023)

Article Geriatrics & Gerontology

Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia

Stefano Gazzina, Mario Grassi, Enrico Premi, Antonella Alberici, Alberto Benussi, Silvana Archetti, Roberto Gasparotti, Martina Bocchetta, David M. Cash, Emily G. Todd, Georgia Peakman, Rhian S. Convery, John C. van Swieten, Lize C. Jiskoot, Harro Seelaar, Raquel Sanchez-Valle, Fermin Moreno, Robert Laforce, Caroline Graff, Matthis Synofzik, Daniela Galimberti, James B. Rowe, Mario Masellis, Maria Carmela Tartaglia, Elizabeth Finger, Rik Vandenberghe, Alexandre de Mendonca, Fabrizio Tagliavini, Chris R. Butler, Isabel Santana, Alexander Gerhard, Isabelle Le Ber, Florence Pasquier, Simon Ducharme, Johannes Levin, Adrian Danek, Sandro Sorbi, Markus Otto, Jonathan D. Rohrer, Barbara Borroni

Summary: This study investigated the relationship between GRN mutations and frontotemporal dementia and applied graph theory to analyze cortical thickness data. The results showed that global connectivity was significantly impaired in symptomatic GRN mutation carriers, while local connectivity exhibited perturbation only in carriers with symptoms.

NEUROBIOLOGY OF AGING (2022)

Article Rheumatology

Assessing the Utility of the Montreal Cognitive Assessment in Screening for Cognitive Impairment in Patients With Systemic Lupus Erythematosus

Oshrat E. Tayer-Shifman, Kimberley Yuen, Robin Green, Mahta Kakvan, Patricia Katz, Kathleen S. Bingham, Juan Pablo Diaz-Martinez, Lesley Ruttan, Joan E. Wither, Maria Carmela Tartaglia, Jiandong Su, Dennisse Bonilla, May Y. Choi, Simone Appenzeller, Michelle Barraclough, Dorcas E. Beaton, Zahi Touma

Summary: The Montreal Cognitive Assessment (MoCA) does not have adequate concurrent criterion validity to accurately identify cognitive impairment (CI) in systemic lupus erythematosus (SLE) patients. The inclusion of MoCA in the Automated Neuropsychological Assessment Metrics (ANAM) does not significantly improve the accuracy of ANAM.

ARTHRITIS CARE & RESEARCH (2023)

Letter Clinical Neurology

CBD diagnostic criteria: exclusions as important as inclusions

Irene Litvan, Anthony E. Lang, Melissa Armstrong

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Article Clinical Neurology

Multisite ALLFTD study modeling progressive empathy loss from the earliest stages of behavioral variant frontotemporal dementia

Gianina Toller, Yann Cobigo, Patrick Callahan, Brian S. Appleby, Danielle Brushaber, Kimiko Domoto-Reilly, Leah K. Forsberg, Nupur Ghoshal, Jonathan Graff-Radford, Neil R. Graff-Radford, Murray Grossman, Hilary W. Heuer, John Kornak, Walter Kremers, Maria Lapid, Gabriel Leger, Irene Litvan, Ian R. Mackenzie, Maria B. Pascual, Eliana M. Ramos, Katya Rascovsky, Julio C. Rojas, Adam M. Staffaroni, Maria C. Tartaglia, Arthur Toga, Sandra Weintraub, Zbigniew K. Wszolek, Brad F. Boeve, Adam L. Boxer, Howard J. Rosen, Katherine P. Rankin

Summary: This study modeled the changes in empathy in behavioral variant frontotemporal dementia (bvFTD) and found that empathic concern and perspective taking decline in the early stages of the disease regardless of genetic factors. The loss of empathy is progressive and correlates with subcortical atrophy.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia

David J. Whiteside, Maura Malpetti, P. Simon Jones, Boyd C. P. Ghosh, Ian Coyle-Gilchrist, John C. van Swieten, Harro Seelaar, Lize Jiskoot, Barbara Borroni, Raquel Sanchez-Valle, Fermin Moreno, Robert Laforce, Caroline Graff, Matthis Synofzik, Daniela Galimberti, Mario Masellis, Maria Carmela Tartaglia, Elizabeth Finger, Rik Vandenberghe, Alexandre de Mendonca, Fabrizio Tagliavini, Chris R. Butler, Isabel Santana, Isabelle Le Ber, Alexander Gerhard, Simon Ducharme, Johannes Levin, Adrian Danek, Markus Otto, Sandro Sorbi, Florence Pasquier, Arabella Bouzigues, Lucy L. Russell, Jonathan D. Rohrer, James B. Rowe, Timothy Rittman

Summary: This study investigated the role of changes in functional networks in predicting cognitive decline and conversion to symptomatic disease in familial frontotemporal dementia (FTD). The study found a characteristic pattern of dynamic network changes in FTD, which were correlated with neuropsychological impairment. Among presymptomatic mutation carriers, this pattern of network dynamics was more prominent in those who later converted to the symptomatic phase. Baseline network dynamic changes predicted future cognitive decline in symptomatic participants and older presymptomatic participants.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

The Rossy Progressive Supranuclear Palsy Centre: Creation and Initial Experience

Blas Couto, Susan Fox, Maria Carmela Tartaglia, Ekaterina Rogaeva, Jeffrey Antwi, Puja Bhakta, Gabor G. Kovacs, Anthony E. E. Lang

Summary: The study focuses on the development and initial experience of the Rossy PSP Centre in Canada, which aims to advance clinical and basic research in progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS). The study collects extensive demographic and longitudinal clinical information using standardized forms, as well as biofluids for genetic analysis and neuroimaging research protocols. The preliminary results show a typical distribution of phenotypes, demographics, and response to symptomatic treatments in the cohort. Future steps include enrolling patients in earlier stages, developing biomarkers, and fast-tracking well-characterized patients into clinical trials.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2023)

Article Psychiatry

Neuropsychiatric Symptom Burden across Neurodegenerative Disorders and its Association with Function

Daniel Kapustin, Shadi Zarei, Wei Wang, Malcolm A. Binns, Paula M. McLaughlin, Agessandro Abrahao, Sandra E. Black, Michael Borrie, David Breen, Leanna Casaubon, Dar Dowlatshahi, Elizabeth Finger, Corinne E. Fischer, Andrew Frank, Morris Freedman, David Grimes, Ayman Hassan, Mandar Jog, Donna Kwan, Anthony Lang, Brian Levine, Jennifer Mandzia, Connie Marras, Mario Masellis, Joseph B. Orange, Stephen Pasternak, Alicia Peltsch, Bruce G. Pollock, Tarek K. Rajji, Angela Roberts, Demetrios Sahlas, Gustavo Saposnik, Dallas Seitz, Christen Shoesmith, Alisia Southwell, Thomas D. L. Steeves, Kelly Sunderland, Richard H. Swartz, Brian Tan, David F. Tang-Wai, Maria Carmela Tartaglia, Angela Troyer, John Turnbull, Lorne Zinman, Sanjeev Kumar

Summary: Neuropsychiatric symptoms (NPS) vary in frequency and severity across different neurodegenerative disorders, with frontotemporal dementia (FTD) having the highest occurrence. The association between NPS burden and function differs among disorders, highlighting the need for individualized clinical interventions.

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2023)

Article Clinical Neurology

Language impairment in the genetic forms of behavioural variant frontotemporal dementia

Kiran Samra, Amy M. MacDougall, Arabella Bouzigues, Martina Bocchetta, David M. Cash, Caroline Greaves, Rhian S. Convery, John C. van Swieten, Harro Seelaar, Lize Jiskoot, Fermin Moreno, Raquel Sanchez-Valle, Robert Laforce, Caroline Graff, Mario Masellis, Maria Carmela Tartaglia, James B. Rowe, Barbara Borroni, Elizabeth Finger, Matthis Synofzik, Daniela Galimberti, Rik Vandenberghe, Alexandre de Mendonca, Christopher R. Butler, Alexander Gerhard, Simon Ducharme, Isabelle Le Ber, Pietro Tiraboschi, Isabel Santana, Florence Pasquier, Johannes Levin, Markus Otto, Sandro Sorbi, Jonathan D. Rohrer, Lucy L. Russell

Summary: The study found that about 76% of patients with genetic bvFTD have language impairments, characterized by impaired functional communication, decreased fluency, and impaired sentence comprehension. There are differences in the extent of brain atrophy in specific language regions and language symptoms among different genetic types of patients. This research is helpful for further understanding the language phenotype associated with genetic bvFTD, especially in accurate stratification and monitoring of disease progression in clinical trials.

JOURNAL OF NEUROLOGY (2023)

Article Multidisciplinary Sciences

Nicked tRNAs are stable reservoirs of tRNA halves in cells and biofluids

Bruno Costa, Marco Li Calzi, Mauricio Castellano, Valentina Blanco, Ernesto Cuevasanta, Irene Litvan, Pavel Ivanov, Kenneth Witwer, Alfonso Cayota, Juan Pablo Tosar

Summary: This study reveals the stability and function of nonvesicular extracellular RNAs (nv-exRNAs), particularly tRNA-derived small RNAs (tDRs), in human biofluids. It shows that traditional molecular biology methods can result in the denaturation of nicked tRNAs, leading to the production of artifactual tDRs. Enzymatic repair and chromatographic separation were used to regenerate full-length tRNAs and separate nicked tRNAs from tDRs, respectively.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Meeting Abstract Clinical Neurology

Differences for Verbal Fluency Decline in Progressive Supranuclear Palsy

Leonardino Digma, Teodoro del Ser, Irene Litvan, Ece Bayram

NEUROLOGY (2023)

暂无数据